출판 : MarketsandMarkets（마켓츠앤드마켓츠）출판년월 : 2022년04월
어깨 건판손상 치료 시장 : 모달리티[수술(관절경검사, 어깨관절치환술, 건 수복), 물리치료(장구, 냉압박), 약물요법(항염증약, 주사), 정형외과] – 2026년까지의 세계 예측
Rotator Cuff Injury Treatment Market by Modality (Surgical (Arthroscopy, Shoulder Replacement, Tendon Repair), Physiotherapy (Braces, Cold Compression), Drug Therapeutics (Anti-inflammatory Drugs, Injections), Orthobiologics) -Global Forecast to 2026
| 페이지수 | 117 |
| 도표수 | 70 |
| 구성 | 영문조사보고서 |
| 가격 |
The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices, increase in the aging population with osteoarthritis, strong focus of players towards launch of highly advanced arthroscopic treatment devices.
세계 회전근개 부상 치료 시장은 예측 기간 동안 CAGR 4.7%로 2021년 9억 8,900만 달러에서 2026년 12억 4,400만 달러에 이를 것으로 예상됩니다. 이 시장의 성장을 촉진하는 주요 요인에는 스포츠 관련 어깨 부상의 증가, 관절경 수술 장치의 기술 발전, 골관절염을 동반한 고령화 인구 증가, 첨단 관절경 치료 장치 출시에 대한 플레이어의 강한 집중 등이 있습니다.
On the other hand, a dearth of skilled professionals, a high surgical treatment failure rate, and its high cost are major challenges faced by market players providing rotator cuff injury treatment products.
The COVID-19 pandemic is an unprecedented crisis that has significantly strained healthcare providers, healthcare infrastructure, and healthcare systems worldwide. The COVID-19 pandemic had a remarkable change in several aspects of medical practice. Elective surgeries, including orthopedic surgery, were canceled worldwide, allowing hospitals to accommodate more COVID-19 patients and completely focus on reducing the possible risk of infection among healthcare workers. According to The CovidSurg Collaborative, a 120-country research initiative formed to analyze the impact of the COVID-19 pandemic on surgeries, around 28.4 million elective surgeries worldwide will be canceled or postponed in 2020, based on 12 weeks of peak disruption to hospital services due to COVID-19. The rotator cuff injury treatment market was also impacted due to restrictions on the organized temporary closure of surgical centers, hospital access restriction for non-essential care, limited access to clinics, implementation of social distancing measures, nationwide lockdowns, and the slowdown of in-patient flow and referrals.
“The surgical or curative treatment to capture the largest share in rotator cuff injury treatment market, by type during the forecast period.”
The surgical treatment segment is expected to hold the largest share of rotator cuff injury treatment market, during the forecast period. This is attributable to the high adoption due to the increasing prevalence of rotator cuff injuries majorly among sportspersons, rising awareness activities by major market players across key countries, and the availability of medical reimbursements for surgical treatment of rotator cuff rupture. Additionally, the increase in the preference of shoulder arthroscopy for the treatment rotator cuff tear among surgeons and the growing awareness about the benefits associated with arothrocopic repair such as lower risk of complications, quick recovery, low rate of post surgical infections are likely to play a significant role in propelling the growth of the segment.
“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The rotator cuff injury treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. significant increase in its geriatric and patient population for orthopedic diseases, growing adoption of orthopedic bracing products in developing nations of Asia Pacific, growing presence of rotator cuff injury treatment devices and drugs manufacturers in the country, increase in the initiatives by the government to promote sports, and growing adoption of new surgical devices for rotator cuff tears launched by local manufacturers are likely to support the growth of the market in the region.
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
• By Designation: C-level: 26%, D-level: 30%, and Others: 44%
• By Region: North America: 40%, Europe: 31%, APAC: 20%, Latin America: 6%, and the Middle East & Africa: 3%
Arthrex (US), Stryker Corporation (US), Smith & Nephew (UK), Johnson & Johnson (DePuy Synthes) (US), Zimmer Biomet (US), CONMED Corporation (US), Integra LifeSciences Corporation (US), LimaCorporate (Italy), FH ORTHOPEDICS S.A.S. (France), Evolutis India Pvt Ltd. (India), DJO Global (US), 3S Ortho (France), Breg, Inc. (US), GPC Medical Ltd. (India), and Parcus Medical (US).
Research Coverage
This report studies the global rotator cuff injury treatment market based on the treatment type, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global in rotator cuff injury treatment market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 10)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. – 13)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 TREATMENT USAGE-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. – 22)
3.1 ROTATOR CUFF INJURY TREATMENT MARKET
3.2 ROTATOR CUFF INJURY TREATMENT MARKET, BY TYPE
4 MARKET OVERVIEW (Page No. – 23)
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 INDUSTRY GROWTH OPPORTUNITIES
4.2.1.1 Rising number of sports-related shoulder injuries
4.2.1.2 Rising technological advancements in rotator cuff rupture devices
4.2.1.3 Growing public-private funding grants and educational awareness initiatives
4.2.1.4 Increasing risk of osteoarthritis in the geriatric population
4.2.1.5 Growing developments in orthobiologics
4.2.2 BURNING ISSUES AND CHALLENGES
4.2.2.1 High costs associated with arthroscopic surgery instruments
4.2.2.2 High failure rates of rotator cuff treatment
4.2.2.3 Shortage of trained orthopedic professionals
4.2.3 COVID-19 SPECIFIC TRENDS
4.3 REGULATORY LANDSCAPE
4.3.1 NORTH AMERICA
4.3.1.1 US
4.3.1.2 Canada
4.3.2 EUROPE
4.3.3 ASIA PACIFIC
4.3.3.1 India
4.3.3.2 Japan
4.3.3.3 China
4.3.3.4 India
4.4 REIMBURSEMENT SCENARIO
4.5 PRICING TREND ANALYSIS
4.6 CLINICAL RESEARCH PIPELINE
4.6.1 ROTATOR CUFF REPAIR TREATMENT
4.7 PATENT ANALYSIS
5 ROTATOR CUFF INJURY TREATMENT MARKET, BY TYPE (Page No. – 46)
5.1 INTRODUCTION
5.2 SURGICAL OR CURATIVE TREATMENT
5.2.1 ARTHROSCOPY (TENDON REPAIR)
5.2.2 TRADITIONAL/OPEN SURGERIES
5.2.2.1 Shoulder replacement surgeries
5.2.2.2 Open tendon repair/transfer
5.3 PHYSIOTHERAPY/PALLIATIVE TREATMENT
5.3.1 ORTHOPEDIC BRACES
5.3.2 COLD COMPRESSION
5.4 PHARMACEUTICAL DRUGS/SYMPTOMATIC OR PREVENTIVE TREATMENT
5.4.1 ANTI-INFLAMMATORY DRUGS AND PAIN KILLERS
5.4.2 INJECTIONS
5.5 ORTHOBIOLOGICS
6 ROTATOR CUFF INJURY TREATMENT MARKET, BY REGION (Page No. – 52)
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA PACIFIC
6.5 LATIN AMERICA
6.6 MIDDLE EAST & AFRICA
7 COMPETITIVE LANDSCAPE (Page No. – 56)
7.1 OVERVIEW
7.1.1 KEY PLAYER STRATEGIES
7.2 LIST OF KEY PLAYERS OPERATING IN EACH TREATMENT SPACE
7.2.1 PRODUCT PORTFOLIO/DEVELOPMENT PIPELINE
7.2.2 KEY STRATEGIES/RIGHT TO WIN
7.3 COMPETITIVE SCENARIO
7.3.1 ROTATOR CUFF INJURY TREATMENT MARKET: PRODUCT LAUNCHES & REGULATORY APPROVALS
7.3.2 ROTATOR CUFF INJURY TREATMENT MARKET: DEALS
7.3.3 ROTATOR CUFF INJURY TREATMENT MARKET: OTHER DEVELOPMENTS
7.3.4 COMPETITIVE LEADERSHIP MAPPING
7.3.5 STARS
7.3.6 PERVASIVE PLAYERS
7.3.7 EMERGING LEADERS
7.3.8 PARTICIPANTS
7.4 FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF INJURY TREATMENT MARKET
7.4.1 TREATMENT PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ROTATOR CUFF INJURY TREATMENT MARKET
8 COMPANY PROFILES (Page No. – 67)
8.1 KEY PLAYERS
8.1.1 STRYKER CORPORATION
8.1.1.1 Business overview
8.1.1.2 Products offered
8.1.1.3 Recent developments
8.1.1.4 MnM view
8.1.2 JOHNSON & JOHNSON
8.1.2.1 Business overview
8.1.2.2 Products offered
8.1.2.3 Recent developments
8.1.2.4 MnM view
8.1.3 SMITH & NEPHEW
8.1.3.1 Business overview
8.1.3.2 Products offered
8.1.3.3 Recent developments
8.1.3.4 MNM view
8.1.4 ARTHREX
8.1.4.1 Business overview
8.1.4.2 Products offered
8.1.4.3 Recent developments
8.1.5 ZIMMER BIOMET
8.1.5.1 Business overview
8.1.5.2 Products offered
8.1.6 INTEGRA LIFESCIENCES
8.1.6.1 Business Overview
8.1.6.2 Products offered
8.1.6.3 Recent developments
8.1.7 LIMACORPORATE S.P.A
8.1.7.1 Business Overview
8.1.7.2 Products offered
8.1.7.3 Recent developments
8.1.8 DJO GLOBAL, INC.
8.1.8.1 Business overview
8.1.8.2 Products offered
8.1.8.3 Recent developments
8.1.9 EVOLUTIS
8.1.9.1 Business overview
8.1.9.2 Products offered
8.1.10 GROUP FH ORTHO
8.1.10.1 Business Overview
8.1.10.2 Products offered
8.1.10.3 Recent developments
8.1.11 CONMED CORPORATION
8.1.11.1 Business overview
8.1.11.2 Products offered
8.1.12 3S ORTHO
8.1.12.1 Business overview
8.1.12.2 Products offered
8.1.13 ANIKA THERAPEUTICS, INC. (PARCUS MEDICAL)
8.1.13.1 Business overview
8.1.13.2 Products offered
8.1.13.3 Recent developments
8.1.14 GPC MEDICAL LTD.
8.1.14.1 Business overview
8.1.14.2 Products offered
8.1.15 BREG, INC.
8.1.15.1 Business overview
8.1.15.2 Products offered
8.1.15.3 Recent developments
9 APPENDIX (Page No. – 104)
9.1 DISCUSSION GUIDE
9.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
9.3 RELATED REPORTS
9.4 AVAILABLE CUSTOMIZATIONS
LIST OF TABLES (30 Tables)
TABLE 1 NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION (2019 VS. 2050)
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 7 REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020)
TABLE 8 REIMBURSEMENT CODES FOR PHYSICIAN SERVICES (AS OF 2020)
TABLE 9 AVERAGE PRICE OF ROTATOR CUFF TREATMENT INSTRUMENTS, BY REGION COUNTRY, 2020 (USD)
TABLE 10 ROTATOR CUFF REPAIR: INDICATIVE LIST OF ONGOING CLINICAL TRIALS (AS OF JANUARY 2018)
TABLE 11 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS, JANUARY 2018–OCTOBER 2021
TABLE 12 KEY DEALS, JANUARY 2018–OCTOBER 2021
TABLE 13 OTHER KEY DEVELOPMENTS, JANUARY 2018–OCTOBER 2021
TABLE 14 TREATMENT PRODUCT FOOTPRINT OF COMPANIES
TABLE 15 REGIONAL FOOTPRINT OF COMPANIES
TABLE 16 STRYKER CORPORATION: BUSINESS OVERVIEW
TABLE 17 JOHNSON & JOHNSON: BUSINESS OVERVIEW
TABLE 18 SMITH & NEPHEW: BUSINESS OVERVIEW
TABLE 19 ARTHREX: BUSINESS OVERVIEW
TABLE 20 ZIMMER BIOMET: BUSINESS OVERVIEW
TABLE 21 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
TABLE 22 LIMACORPORATE: BUSINESS OVERVIEW
TABLE 23 DJO GLOBAL, INC.: BUSINESS OVERVIEW
TABLE 24 EVOLUTIS: BUSINESS OVERVIEW
TABLE 25 GROUP FH ORTHO: BUSINESS OVERVIEW
TABLE 26 CONMED CORPORATION: BUSINESS OVERVIEW
TABLE 27 3S ORTHO: BUSINESS OVERVIEW
TABLE 28 ANIKA THERAPEUTICS: BUSINESS OVERVIEW
TABLE 29 GPC MEDICAL LTD.: BUSINESS OVERVIEW
TABLE 30 BREG, INC.: BUSINESS OVERVIEW
LIST OF FIGURES (23 Figures)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: ROTATOR CUFF INJURY TREATMENT MARKET
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION BASED ON TREATMENT UTILIZATION METHODOLOGY
FIGURE 5 MARKET SIZE ESTIMATION BASED ON REVENUE MAPPING METHODOLOGY
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES IN THE US PER 1000 INHABITANATS (2020)
FIGURE 8 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
FIGURE 9 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
FIGURE 10 TOP 10 PATENT APPLICANTS FOR ROTATOR CUFF REPAIR (JANUARY 2011 TO OCTOBER 2021)
FIGURE 11 NUMBER OF GRANTED PATENTS AND PATENT APPLICATIONS (JANUARY 2011 TO OCTOBER 2021)
FIGURE 12 PATENT DOCUMENTS FOR ROTATOR CUFF REPAIR, BY LEGAL STATUS (JANUARY 2011 TO OCTOBER 2021)
FIGURE 13 REGIONAL ANALYSIS OF PATENTS GRANTED FOR ROTATOR CUFF REPAIR, 2020
FIGURE 14 ROTATOR CUFF INJURY TREATMENT MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
FIGURE 15 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 16 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
FIGURE 17 SMITH & NEPHEW: COMPANY SNAPSHOT (2020)
FIGURE 18 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
FIGURE 19 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
FIGURE 20 LIMACORPORATE: COMPANY SNAPSHOT (2020)
FIGURE 21 DJO GLOBAL, INC.: COMPANY SNAPSHOT (2020)
FIGURE 22 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 23 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2020)
